Aerami Therapeutics Overview
- Year Founded
-
2010

- Status
-
Private
- Employees
-
16

- Latest Deal Type
-
Mezzanine
- Financing Rounds
-
17
- Investments
-
1
Aerami Therapeutics General Information
Description
Developer of therapies intended for the treatment of severe respiratory and chronic diseases. The company offers inhaled therapies for the treatment of pulmonary arterial hypertension, improving the effectiveness of inhaled drugs, delivering better clinical outcomes, and providing a shorter treatment time.
Contact Information
Website
www.aerami.comCorporate Office
- 600 Park Offices Drive
- Suite 300
- Durham, NC 27709
- United States
Corporate Office
- 600 Park Offices Drive
- Suite 300
- Durham, NC 27709
- United States
Aerami Therapeutics Timeline
Aerami Therapeutics Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Aerami Therapeutics Comparisons
Industry
Financing
Details
Aerami Therapeutics Competitors (10)
One of Aerami Therapeutics’s 10 competitors is Flowonix, a Formerly VC-backed company based in Mount Olive, NJ.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Flowonix | Formerly VC-backed | Mount Olive, NJ | ||||
MannKind | Formerly VC-backed | Westlake Village, CA | ||||
Pearl Therapeutics | Formerly VC-backed | Redwood City, CA | ||||
Sensulin | Venture Capital-Backed | Oklahoma City, OK | ||||
Beta-O2 Technologies | Venture Capital-Backed | Rosh Haayin, Israel |
Aerami Therapeutics Signals
Aerami Therapeutics Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Aerami Therapeutics Investments (1)
Aerami Therapeutics’s most recent deal was a Buyout/LBO with Harmony Biopharm. The deal was made on 29-Aug-2017.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Harmony Biopharm | 29-Aug-2017 | Buyout/LBO | Buildings and Property |
Aerami Therapeutics FAQs
-
When was Aerami Therapeutics founded?
Aerami Therapeutics was founded in 2010.
-
Where is Aerami Therapeutics headquartered?
Aerami Therapeutics is headquartered in Durham, NC.
-
What is the size of Aerami Therapeutics?
Aerami Therapeutics has 16 total employees.
-
What industry is Aerami Therapeutics in?
Aerami Therapeutics’s primary industry is Drug Delivery.
-
Is Aerami Therapeutics a private or public company?
Aerami Therapeutics is a Private company.
-
What is Aerami Therapeutics’s current revenue?
The current revenue for Aerami Therapeutics is
. -
How much funding has Aerami Therapeutics raised over time?
Aerami Therapeutics has raised $194M.
-
Who are Aerami Therapeutics’s investors?
Silver Rock Group, GPB Capital, Molex Ventures, and Aegis Capital Group have invested in Aerami Therapeutics.
-
Who are Aerami Therapeutics’s competitors?
Flowonix, MannKind, Pearl Therapeutics, Sensulin, and Beta-O2 Technologies are some of the 10 competitors of Aerami Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »